Cargando…
Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia”
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487093/ https://www.ncbi.nlm.nih.gov/pubmed/32952555 http://dx.doi.org/10.1155/2020/1834190 |
_version_ | 1783581421247397888 |
---|---|
author | Vitkevičienė, Aida Skiauterytė, Giedrė Žučenka, Andrius Stoškus, Mindaugas Gineikienė, Eglė Borutinskaitė, Veronika Griškevičius, Laimonas Navakauskienė, Rūta |
author_facet | Vitkevičienė, Aida Skiauterytė, Giedrė Žučenka, Andrius Stoškus, Mindaugas Gineikienė, Eglė Borutinskaitė, Veronika Griškevičius, Laimonas Navakauskienė, Rūta |
author_sort | Vitkevičienė, Aida |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7487093 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-74870932020-09-17 Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia” Vitkevičienė, Aida Skiauterytė, Giedrė Žučenka, Andrius Stoškus, Mindaugas Gineikienė, Eglė Borutinskaitė, Veronika Griškevičius, Laimonas Navakauskienė, Rūta J Oncol Corrigendum Hindawi 2020-09-04 /pmc/articles/PMC7487093/ /pubmed/32952555 http://dx.doi.org/10.1155/2020/1834190 Text en Copyright © 2020 Aida Vitkevičienė et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Corrigendum Vitkevičienė, Aida Skiauterytė, Giedrė Žučenka, Andrius Stoškus, Mindaugas Gineikienė, Eglė Borutinskaitė, Veronika Griškevičius, Laimonas Navakauskienė, Rūta Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia” |
title | Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia” |
title_full | Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia” |
title_fullStr | Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia” |
title_full_unstemmed | Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia” |
title_short | Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia” |
title_sort | corrigendum to “hdac and hmt inhibitors in combination with conventional therapy: a novel treatment option for acute promyelocytic leukemia” |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487093/ https://www.ncbi.nlm.nih.gov/pubmed/32952555 http://dx.doi.org/10.1155/2020/1834190 |
work_keys_str_mv | AT vitkevicieneaida corrigendumtohdacandhmtinhibitorsincombinationwithconventionaltherapyanoveltreatmentoptionforacutepromyelocyticleukemia AT skiauterytegiedre corrigendumtohdacandhmtinhibitorsincombinationwithconventionaltherapyanoveltreatmentoptionforacutepromyelocyticleukemia AT zucenkaandrius corrigendumtohdacandhmtinhibitorsincombinationwithconventionaltherapyanoveltreatmentoptionforacutepromyelocyticleukemia AT stoskusmindaugas corrigendumtohdacandhmtinhibitorsincombinationwithconventionaltherapyanoveltreatmentoptionforacutepromyelocyticleukemia AT gineikieneegle corrigendumtohdacandhmtinhibitorsincombinationwithconventionaltherapyanoveltreatmentoptionforacutepromyelocyticleukemia AT borutinskaiteveronika corrigendumtohdacandhmtinhibitorsincombinationwithconventionaltherapyanoveltreatmentoptionforacutepromyelocyticleukemia AT griskeviciuslaimonas corrigendumtohdacandhmtinhibitorsincombinationwithconventionaltherapyanoveltreatmentoptionforacutepromyelocyticleukemia AT navakauskieneruta corrigendumtohdacandhmtinhibitorsincombinationwithconventionaltherapyanoveltreatmentoptionforacutepromyelocyticleukemia |